<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01477996</url>
  </required_header>
  <id_info>
    <org_study_id>FR-7-CI-2011</org_study_id>
    <nct_id>NCT01477996</nct_id>
  </id_info>
  <brief_title>Pain After Intravitreal Therapy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized clinical trial is comparing two different needles (27 gauge versus 30 gauge)
      for intravitreal therapy (IVT). Standardized questionnaires and pain scales should allow for
      standard recommendation regarding the optimal needle size for IVT.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose: To evaluate the influence of the type of the needle on pain scores after
      intravitreal therapy (IVT).

      Design: Randomized clinical trial Methods: A total of 200 patients, treated with an IVT for
      exudative age-related macular degeneration (AMD) or a vascular retinal disease, will be
      included and randomly assigned to be treated with either a 27-gauge needle (group 1) or a
      30-gauge needle (group 2). After IVt the patient has to fill out a standardized questionnaire
      including pain scores on the visual analog scale after the surgical procedure.

      Regression analysis of the scaled questionnaires should allow for a standard recommendation
      regarding the optimal needle size for minimal subjective pain during IVT.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analoge Scale</measure>
    <time_frame>1 day, after the intravitreal therapy (IVT)</time_frame>
    <description>pain scores on the visual analog scale after the IVT</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>patients demographic data</measure>
    <time_frame>1 day, record of patients data before or after intravitreal therapy (IVT)</time_frame>
    <description>age, gender, number of IVT, surgeon, prior surgical procedures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baker scale</measure>
    <time_frame>1 day, after the intravitreal therapy (IVT)</time_frame>
    <description>pain scores on the baker scale after the IVT</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>27-gauge needle</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>30-gauge needle</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>27-gauge</intervention_name>
    <description>27-gauge needle for IVT</description>
    <arm_group_label>Group 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>30-gauge</intervention_name>
    <description>30-gauge needle for IVT</description>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  vitrearetinal disease including age-related macular degeneration,

          -  clinical significant macular edema due to diabetic retinopathy or other vascular
             disorders

          -  treatment with intravitreal therapy

        Exclusion Criteria:

          -  missing informed consent

          -  age under 50 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>51 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christiane I Falkner-Radler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Susanne Binder, MD</last_name>
    <role>Study Chair</role>
    <affiliation>The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery, Department of Ophthalmology; Rudolf Foundation Clinic, Juchgasse 25</name>
      <address>
        <city>Vienna</city>
        <zip>1030</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 8, 2011</study_first_submitted>
  <study_first_submitted_qc>November 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 23, 2011</study_first_posted>
  <last_update_submitted>January 24, 2016</last_update_submitted>
  <last_update_submitted_qc>January 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery</investigator_affiliation>
    <investigator_full_name>Dr. Christiane I. Falkner-Radler</investigator_full_name>
    <investigator_title>Principial investigator</investigator_title>
  </responsible_party>
  <keyword>intravitreal therapy</keyword>
  <keyword>pain scales</keyword>
  <keyword>gauge</keyword>
  <keyword>Pain Scores</keyword>
  <keyword>Visual Analog Scale</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

